Clinical Tool for Cystic Fibrosis Waitlist Mortality
Trial Summary
What is the purpose of this trial?
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Mobile Spirometry and Survey for cystic fibrosis?
How does this treatment for cystic fibrosis differ from other treatments?
This treatment is unique because it involves a clinical tool that uses a predictive algorithm to detect rapid lung function decline in cystic fibrosis patients earlier than current methods. This allows for earlier intervention and potentially better outcomes, unlike traditional treatments that may not detect rapid decline as quickly.12367
Eligibility Criteria
This trial is for individuals with Cystic Fibrosis who are on the waitlist for a lung transplant and have bought a home spirometer. It's not suitable for those without Cystic Fibrosis, or people who can't read or use a computer/smartphone to access the required mobile app.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Participants use a mobile application for home spirometry and patient-reported outcomes to track health status and update lung allocation scores.
Follow-up
Participants are monitored for changes in lung allocation score and survival to transplant.
Treatment Details
Interventions
- Mobile Spirometry and Survey
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor